InspireMD

company

About

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.

  • 51 - 100

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$10M
Industries
Biopharma,Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2005
Number Of Employee
51 - 100
Operating Status
Active

InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.

The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD’s mission is to utilize its proprietary technology to make its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: embolic showers, restenosis, and late stent thrombosis.

InspireMD intends to pursue applications of its innovative technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
InspireMD has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Oct 24, 2013 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 24, 2013 Post-IPO Debt $10M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
InspireMD is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Post-IPO Debt